Immunotherapies for cancer rely on recruiting the patient's immune system, but they still fall far short of tapping into the entire arsenal of the body's natural defenses. In fact, most such therapies draw on one type of ...
Mar 23, 2022
0
77
Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of ...
Mar 23, 2022
0
138
The prognosis for ovarian cancer patients is grim: Less than half of high-grade serous ovarian cancer (HGSC) patients survive past five years from diagnosis. Initially, the tumors typically respond well to chemotherapy, but ...
Feb 23, 2022
0
18
Every year, roughly 550 women develop ovarian cancer in Finland. Ovarian cancer is difficult to treat and it is commonly fatal, with 320 women dying of ovarian cancer annually in Finland.
Feb 11, 2022
0
12
Ovarian granulosa cell tumors are a rare type of ovarian cancer that affect the ovaries and fallopian tubes, and can extend further into the pelvis and lymph nodes. Treatment typically follows the same guidelines as other ...
Dec 3, 2021
0
4
Early detection of ovarian cancer helps boost a woman's survival, and the U.S. Food and Drug Administration on Monday approved a new imaging drug that can help spot tumors during surgery.
Nov 29, 2021
0
0
A group of scientists at the Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences proposed a new method with Modality-based Attention and Contextual (MAC)-Net to better help ...
Nov 9, 2021
0
19
A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system's cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine ...
Nov 6, 2021
0
78
In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Principal investigator ...
Oct 8, 2021
0
29
A research team led by Prof. Dai Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) recently announced the constitutive BAK/MCL1 complexes could predict chemotherapy ...
Sep 15, 2021
0
2
